India to Poland: Etoposide Export Trade Route
India has recorded 47 verified shipments of Etoposide exported to Poland, representing a combined trade value of $395.6K USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $8.4K USD. The leading Indian exporter is INTAS PHARMACEUTICALS LIMITED, which accounts for 64% of total export value with 25 shipments worth $253.2K USD. On the buying side, ACCORD HEALTHCARE POLSKA SP. Z.O.O. is the largest importer in Poland with $111.6K USD in purchases. The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , NV REMEDIES PRIVATE LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Poland Etoposide corridor is one of India's established pharmaceutical export routes, with 47 shipments documented worth a combined $395.6K USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED, which alone accounts for roughly 64% of all export value, reflecting the consolidated nature of India's etoposide manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $8.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with etoposide's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 33.2%, placing it at rank #9 among India's top etoposide export destinations globally.
On the import side, key buyers of Indian etoposide in Poland include ACCORD HEALTHCARE POLSKA SP. Z.O.O. , ACCORD HEALTHCARE POLSKA SP. Z O.O., Accord Healthcare Polska Sp. z o.o. and 10 others. ACCORD HEALTHCARE POLSKA SP. Z.O.O. is the single largest importer with 17 shipments valued at $111.6K USD.
Route Characteristics
- Average transit18 days
- Peak seasonQ4
- Primary modeSea freight
- Top portMUNDRA SEA (INMUN1)
Market Position
- Global rank#9
- Annual growth+33.2%
- Demand growth+27.7%
- Regulatory ease80/100
Top 10 Indian Etoposide Exporters to Poland
Showing top 10 of 5 Indian suppliers exporting Etoposide to Poland, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | INTAS PHARMACEUTICALS LIMITED Avg $10.1K per shipment | 25 | $253.2K | 64.0% |
| 2 | INTAS PHARMACEUTICALS LIMITED Avg $6.4K per shipment | 18 | $115.7K | 29.2% |
| 3 | NV REMEDIES PRIVATE LIMITED Avg $13.3K per shipment | 2 | $26.5K | 6.7% |
| 4 | SACRED LEAVES PRIVATE LIMITED Avg $110 per shipment | 1 | $110 | 0.0% |
| 5 | SACRED LEAVES PRIVATE LIMITED Avg $100 per shipment | 1 | $100 | 0.0% |
This table shows the top 10 of 5 Indian companies exporting etoposide to Poland, ranked by total trade value. The listed exporters are: INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , NV REMEDIES PRIVATE LIMITED, SACRED LEAVES PRIVATE LIMITED, SACRED LEAVES PRIVATE LIMITED . INTAS PHARMACEUTICALS LIMITED is the dominant supplier with 25 shipments worth $253.2K USD, giving it a 64% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Top 10 Etoposide Importers in Poland
Showing top 10 of 13 known buyers in Poland receiving Etoposide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian etoposide in Poland include ACCORD HEALTHCARE POLSKA SP. Z.O.O. , ACCORD HEALTHCARE POLSKA SP. Z O.O., Accord Healthcare Polska Sp. z o.o., TO THE ORDER, ACCORD HEALTHCARE POLSKA SP Z O O, among 13 total buyers. The largest importer is ACCORD HEALTHCARE POLSKA SP. Z.O.O. , accounting for $111.6K USD across 17 shipments — representing 28% of all etoposide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ACCORD HEALTHCARE POLSKA SP. Z.O.O. | 17 | $111.6K | 28.2% |
| 2 | ACCORD HEALTHCARE POLSKA SP. Z O.O. | 5 | $63.0K | 15.9% |
| 3 | Accord Healthcare Polska Sp. z o.o. | 3 | $37.0K | 9.3% |
| 4 | TO THE ORDER | 3 | $36.8K | 9.3% |
| 5 | ACCORD HEALTHCARE POLSKA SP Z O O | 4 | $31.8K | 8.0% |
| 6 | ACCORD HEALTHCARE POLSKA SP. Z O.O | 2 | $30.1K | 7.6% |
| 7 | CPC "BIOCON" LLC | 2 | $26.5K | 6.7% |
| 8 | ACCORD HEALTHCARE POLSKA SP. Z.O.O. | 3 | $23.0K | 5.8% |
| 9 | ACCORD HEALTHCARE POLSKA SP ZOO MAGAZYN IMPORTERA UL LUTOMIERSKA | 4 | $18.9K | 4.8% |
| 10 | MAGAZYN IMPORTERAUL LUTOMIERSKA 50 | 1 | $12.7K | 3.2% |
Showing top 10 of 13 Etoposide importers in Poland on this route.
Top 10 Etoposide Formulations Imported by Poland
Showing top 10 of 29 product formulations shipped on the India to Poland Etoposide route, ranked by trade value
Poland imports a wide range of etoposide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMA DRUGS & MEDI ETOPOSIDE INJ,20MG/M — accounts for $73.2K USD across 12 shipments. There are 29 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA DRUGS & MEDI ETOPOSIDE INJ,20MG/M | 12 | $73.2K | 18.5% |
| 2 | PHA.DRU & MEDI, ETOPOSIDE INJ,20MG/ML,10ML(ACCORD-POLAND Each ml contains : Etoposide Ph.Eur. .....20 mg Benz | 2 | $30.1K | 7.6% |
| 3 | PHARMA DRUGS & MEDI ETOPOSIDE INJ USP,20 | 3 | $30.0K | 7.6% |
| 4 | PHARMA DRUG&MED:ETOPOSIDE INJ,20MG/ML,10 | 3 | $27.0K | 6.8% |
| 5 | PHARM DRUG&MED:ETOPOSIDE INJ USP20MG/ML12.5ML(ACO-CZ)EACH ML CONT:ETOPOSIDE PH.EUR 20MG BENZYL ALCOHOL PH.E(ASPERINV) | 1 | $22.8K | 5.8% |
| 6 | PHARM DRUG&MED:ETOPOSIDE INJ USP20MG/ML5ML(ACCORD-POLA)EACH ML CONT:ETOPOSIDE PH.EUR 20MG BENZYL ALCOHOL PH.E (ASPERIN) | 1 | $16.3K | 4.1% |
| 7 | PHARMA DRUGS & MEDI ETOPOSIDE INJ20MG/M | 1 | $15.6K | 3.9% |
| 8 | PHARM DRUG&MED:ETOPOSIDE INJ USP20MG/ML5ML(ACCORD-POLA)EACH ML CONT:ETOPOSIDE PH.EUR. 20MG BENZYL ALCOHOL PH(ASPERINV) | 1 | $15.0K | 3.8% |
| 9 | PHARM DRUG&MED:ETOPOSIDE INJ USP,20MG/ML,5ML(ACCO-BULGA)EACH ML CONT:ETOPOSIDE PH.EUR 20MG BENZYL ALCOHOL PH. (ASPERINV) | 1 | $14.3K | 3.6% |
| 10 | PHA.DRU & MEDI, ETOPOSIDE INJ,20MG/ML,20ML(ACCORD-POLAND Each ml contains :Etoposide Ph.Eur.20 mg Benzyl alcohol Ph.Eur. | 1 | $14.1K | 3.6% |
Showing top 10 of 29 Etoposide formulations imported by Poland on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 77%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
MUNDRA SEA (INMUN1) handles the highest volume with 20 shipments. Transit time averages 18 days by sea.
Market Dynamics
India's etoposide exports to Poland are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 25 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Poland benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , NV REMEDIES PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $8.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as pha.dru & medi, etoposide inj,20mg/ml,10ml(accord-poland each ml contains : etoposide ph.eur. .....20 mg benz and pharma drugs & medi etoposide inj usp,20 , suggesting that buyers in Poland tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, ACCORD HEALTHCARE POLSKA SP. Z.O.O. is the largest importer with 17 shipments worth $111.6K USD — representing 28% of all etoposide imports from India on this route. A total of 13 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $395.6K
- Avg. Shipment
- $8.4K
- Suppliers
- 5
- Buyers
- 13
- Transit (Sea)
- ~18 days
- Annual Growth
- +33.2%
Other Etoposide Routes
Unlock the Full India to Poland Etoposide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 47 shipments on this route.
Frequently Asked Questions — India to Poland Etoposide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Etoposide to Poland?
The leading Indian exporters of Etoposide to Poland are INTAS PHARMACEUTICALS LIMITED, INTAS PHARMACEUTICALS LIMITED , NV REMEDIES PRIVATE LIMITED. INTAS PHARMACEUTICALS LIMITED holds the largest market share at approximately 64% of total trade value on this route.
Q What is the total value of Etoposide exports from India to Poland?
India exports Etoposide to Poland worth approximately $395.6K USD across 47 recorded shipments. The average value per shipment is $8.4K USD.
Q Which ports does India use to ship Etoposide to Poland?
The most active port of origin is MUNDRA SEA (INMUN1) with 20 shipments. Indian exporters primarily use sea freight for this route, with 77% of shipments going by sea and 24% by air.
Q How long does shipping take from India to Poland for Etoposide?
The average transit time for Etoposide shipments from India to Poland is approximately 18 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Poland Etoposide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 33.2% with demand growth tracking at 27.7%. The route is ranked #9 among India's top Etoposide export destinations globally.
Q How many suppliers are active on the India to Poland Etoposide route?
There are currently 5 active Indian suppliers exporting Etoposide to Poland. The market is moderately concentrated with INTAS PHARMACEUTICALS LIMITED accounting for 64% of total shipment value.
Q Who are the main importers of Etoposide from India in Poland?
The leading importers of Indian Etoposide in Poland include ACCORD HEALTHCARE POLSKA SP. Z.O.O. , ACCORD HEALTHCARE POLSKA SP. Z O.O., Accord Healthcare Polska Sp. z o.o., TO THE ORDER, ACCORD HEALTHCARE POLSKA SP Z O O. ACCORD HEALTHCARE POLSKA SP. Z.O.O. is the largest buyer with 17 shipments worth $111.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Poland export trade corridor identified from Indian Customs (DGFT) records for Etoposide.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 13 importers in Poland matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 47 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
47 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists